Dr. Ernie Hawk

In this video, Dr. Ernie Hawk discusses the importance of metrics driven recruitment with defined measures of success. A native of Detroit, MI, Hawk earned his bachelor’s and medical degrees at Wayne State University and his master of public health degree at Johns Hopkins University. He completed an internal medicine internship and residency at Emory University, a medical oncology clinical fellowship at the University of California, San Francisco and a cancer prevention fellowship at NCI. Hawk currently serves as deputy editor for Cancer Prevention Research.

Video Transcript

Hello, I am Dr. Ernie Hawk the Vice President of the Cancer Prevention and Population Sciences at the University of Texas MD Anderson Cancer Center. We at MD Anderson with our colleagues at the other four EMPACT sites are committed to enhancing the participation of minorities in clinical trails.

Cancer takes a huge toll on our population. Cancer Centers attempt to address that burden by providing outstanding patient care and conducting research to improve the future range of effectiveness of options available to patients. But to truly connect to the need, a center’s research must be representative of and relevant to its population.

Therefore trials require the recruitment of participants from diverse backgrounds. This represents an important challenge because our population is increasingly diverse in terms of a host of variables associated with both the risk of developing cancer and treatment related outcomes. Those factors include, among others, race, age, socioeconomic status and geographic location.

To address this challenge, a critical preliminary step for any cancer centers is to first define its catchment area. Secondly, it must have a good understanding of the population of cancer patients within this catchment area particularly with regard to those elements of diversity that bear on risk and outcomes.

Finally it must monitor the entry of patients from the population into the cancer center and then onto its clinical trials. The ultimate goal is for participants enrolled in the center’s therapeutic trials to reflect the diversity of cancer patients in this catchment area. In order to help your institution meet that goal in today’s module, you’ll first learn about the importance of using metric driven recruitment in clinical trials.

Next, you’ll learn about the concept of catchment areas. Lastly, you will gain the skills to gather and analyze the current data and to set your target goals for enrollment. In conclusion now that I’ve introduced you to the challenge and the importance of establishing an informed monitoring system specific to your institution.

I invite you to review the following PowerPoint presentation and complete the learning activity. We at EMPACT are committed to enhancing the participation of minorities in clinical trials and thank you for taking the time to review this module.